Professor | Hongying Zhao | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Hongying Zhao
Contact Information	zhaohongying@hrbmu.edu.cn
Language ability	Chinese, English
Province	Heilongjiang

Upload Avatar (500 x 500)

Name

Hongying Zhao

Contact Information

zhaohongying@hrbmu.edu.cn

Language ability

Chinese, English

Province

Heilongjiang

University/Lab Affiliation and Title	Harbin Medical University
Faculty	College of Bioinformatics Science and Technology
Academic Background & Achievements	2011-2016: PhD in Clinical Medicine, Harbin Medical University 2016: National Scholarship for Doctoral Students
Awards	2019: First Prize in Heilongjiang Provincial University Science and Technology Award 2017: Excellent Teacher Award 2019: Second Prize in Young Teacher Lecture Competition

University/Lab Affiliation and Title

Harbin Medical University

Faculty

College of Bioinformatics Science and Technology

Academic Background & Achievements

2011-2016: PhD in Clinical Medicine, Harbin Medical University
2016: National Scholarship for Doctoral Students

Awards

2019: First Prize in Heilongjiang Provincial University Science and Technology Award
2017: Excellent Teacher Award
2019: Second Prize in Young Teacher Lecture Competition

Areas of Focus	Bioinformatics research of cancer omics big data Artificial intelligence and deep learning Cancer treatment decision-making and prognosis evaluation Construction of bioinformatics platforms
Publications	LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA-target regulations in human diseases, Hongying Zhao, Xiangzhe Yin, Haotian Xu, Kailai Liu, Wangyang Liu, Lixia Wang, Caiyu Zhang, Lin Bo, Xicheng Lan, Shihua Lin, Ke Feng, Shangwei Ning, Yunpeng Zhang, Li Wang, 2023 The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis, Li Wang, Wangyang Liu, Kailai Liu, Lixia Wang, Xiangzhe Yin, Lin Bo, Haotian Xu, Shihua Lin, Ke Feng, Xinyu Zhou, Lin Lin, Meiting Fei, Caiyu Zhang, Shangwei Ning, Hongying Zhao, 2022 LncTarD: a manually-curated database of experimentally-supported functional lncRNA–target regulations in human diseases, Hongying Zhao, Jian Shi, Yunpeng Zhang, Aimin Xie, Lei Yu, Caiyu Zhang, Junjie Lei, Haotian Xu, Zhijun Leng, Tengyue Li, Waidong Huang, Shihua Lin, Li Wang, Yun Xiao, Xia Li, 2020 Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes, Hongying Zhao, Xiaoqin Liu, Lei Yu, Shihua Lin, Caiyu Zhang, Haotian Xu, Zhijun Leng, Waidong Huang, Junjie Lei, Tengyue Li, Jing Li, Fan Yang, Li Wang, 2021 Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer, Hongying Zhao, Xiangzhe Yin, Lixia Wang, Kailai Liu, Wangyang Liu, Lin Bo, Li Wang, 2023 Comprehensive characterization of clonality of driver genes revealing their clinical relevance in colorectal cancer, Jian Shi, Li Wang, Xiangzhe Yin, Lixia Wang, Lin Bo, Kailai Liu, Ke Feng, Shihua Lin, Yanjun Xu, Shangwei Ning, Hongying Zhao, 2022 Identifying functions and prognostic biomarkers of network motifs marked by diverse chromatin states in human cell lines, Li Wang, Hongying Zhao, Jing Li, Yingqi Xu, Wenkang Yin, Yujia Lan, Wenkang Yin, Xiaoqin Liu, Lei Yu, Shihua Lin, Michael Yifei Du, Xia Li, Yun Xiao, Yunpeng Zhang, 2020 Comprehensive identification and potential application of genetic alteration-driven enhancer RNAs for eRNA-targeted therapy in breast cancer, Hongying Zhao, Caiyu Zhang, Lin Bo, Lixia Wang, Wangyang Liu, Yaopeng Shu, Kailai Liu, Ying Liu, Meiting Fei, Li Wang, 2023 Genome-wide DNA methylome analysis reveals a critical role of methylation-dysregulated lncRNAs in autophagy regulation in glioblastoma, Hongying Zhao, Ying Liu, Meiting Fei, Lin Bo, Lixia Wang, Yaopeng Shu, Peiqi Ben, Li Wang, 2023 Identification of somatic mutation-driven enhancers and their clinical utility in breast cancer, Hongying Zhao, Ke Feng, Junjie Lei, Yaopeng Shu, Lin Bo, Ying Liu, Lixia Wang, Wangyang Liu, Shangwei Ning, Li Wang, 2024 Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data, Hongying Zhao, Siwen Zhang, Xiangzhe Yin, Caiyu Zhang, Lixia Wang, Kailai Liu, Haotian Xu, Wangyang Liu, Lin Bo, Shihua Lin, Ke Feng, Lin Lin, Meiting Fei, Shangwei Ning, Li Wang, 2022 Integrated analysis of single-cell and bulk RNA sequencing data reveals immune-related lncRNA-mRNA prognostic signature in triple-negative breast cancer, Hongying Zhao, Lei Yu, Lixia Wang, Xiangzhe Yin, Kailai Liu, Wangyang Liu, Shihua Lin, Li Wang, 2024 A novel method to identify and characterize personalized functional driver lncRNAs in cancer samples, Xuan Zheng, Feng Li, Hongying Zhao, Yongjuan Tang, Ke Xue, Xiaomeng Zhang, Weixin Liang, Rui Zhao, Xingyu Lv, Xinyu Song, Chunlong Zhang, Yanjun Xu, Yunpeng Zhang, 2023 Functional regulations between genetic alteration-driven genes and drug target genes acting as prognostic biomarkers in breast cancer, Li Wang, Lei Yu, Jian Shi, Feng Li, Caiyu Zhang, Haotian Xu, Xiangzhe Yin, Lixia Wang, Shihua Lin, Anastasiia Litvinova, Yanyan Ping, Shangwei Ning, Hongying Zhao, 2022

Areas of Focus

Bioinformatics research of cancer omics big data
Artificial intelligence and deep learning
Cancer treatment decision-making and prognosis evaluation
Construction of bioinformatics platforms

Publications

LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA-target regulations in human diseases, Hongying Zhao, Xiangzhe Yin, Haotian Xu, Kailai Liu, Wangyang Liu, Lixia Wang, Caiyu Zhang, Lin Bo, Xicheng Lan, Shihua Lin, Ke Feng, Shangwei Ning, Yunpeng Zhang, Li Wang, 2023
The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis, Li Wang, Wangyang Liu, Kailai Liu, Lixia Wang, Xiangzhe Yin, Lin Bo, Haotian Xu, Shihua Lin, Ke Feng, Xinyu Zhou, Lin Lin, Meiting Fei, Caiyu Zhang, Shangwei Ning, Hongying Zhao, 2022
LncTarD: a manually-curated database of experimentally-supported functional lncRNA–target regulations in human diseases, Hongying Zhao, Jian Shi, Yunpeng Zhang, Aimin Xie, Lei Yu, Caiyu Zhang, Junjie Lei, Haotian Xu, Zhijun Leng, Tengyue Li, Waidong Huang, Shihua Lin, Li Wang, Yun Xiao, Xia Li, 2020
Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes, Hongying Zhao, Xiaoqin Liu, Lei Yu, Shihua Lin, Caiyu Zhang, Haotian Xu, Zhijun Leng, Waidong Huang, Junjie Lei, Tengyue Li, Jing Li, Fan Yang, Li Wang, 2021
Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer, Hongying Zhao, Xiangzhe Yin, Lixia Wang, Kailai Liu, Wangyang Liu, Lin Bo, Li Wang, 2023
Comprehensive characterization of clonality of driver genes revealing their clinical relevance in colorectal cancer, Jian Shi, Li Wang, Xiangzhe Yin, Lixia Wang, Lin Bo, Kailai Liu, Ke Feng, Shihua Lin, Yanjun Xu, Shangwei Ning, Hongying Zhao, 2022
Identifying functions and prognostic biomarkers of network motifs marked by diverse chromatin states in human cell lines, Li Wang, Hongying Zhao, Jing Li, Yingqi Xu, Wenkang Yin, Yujia Lan, Wenkang Yin, Xiaoqin Liu, Lei Yu, Shihua Lin, Michael Yifei Du, Xia Li, Yun Xiao, Yunpeng Zhang, 2020
Comprehensive identification and potential application of genetic alteration-driven enhancer RNAs for eRNA-targeted therapy in breast cancer, Hongying Zhao, Caiyu Zhang, Lin Bo, Lixia Wang, Wangyang Liu, Yaopeng Shu, Kailai Liu, Ying Liu, Meiting Fei, Li Wang, 2023
Genome-wide DNA methylome analysis reveals a critical role of methylation-dysregulated lncRNAs in autophagy regulation in glioblastoma, Hongying Zhao, Ying Liu, Meiting Fei, Lin Bo, Lixia Wang, Yaopeng Shu, Peiqi Ben, Li Wang, 2023
Identification of somatic mutation-driven enhancers and their clinical utility in breast cancer, Hongying Zhao, Ke Feng, Junjie Lei, Yaopeng Shu, Lin Bo, Ying Liu, Lixia Wang, Wangyang Liu, Shangwei Ning, Li Wang, 2024
Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data, Hongying Zhao, Siwen Zhang, Xiangzhe Yin, Caiyu Zhang, Lixia Wang, Kailai Liu, Haotian Xu, Wangyang Liu, Lin Bo, Shihua Lin, Ke Feng, Lin Lin, Meiting Fei, Shangwei Ning, Li Wang, 2022
Integrated analysis of single-cell and bulk RNA sequencing data reveals immune-related lncRNA-mRNA prognostic signature in triple-negative breast cancer, Hongying Zhao, Lei Yu, Lixia Wang, Xiangzhe Yin, Kailai Liu, Wangyang Liu, Shihua Lin, Li Wang, 2024
A novel method to identify and characterize personalized functional driver lncRNAs in cancer samples, Xuan Zheng, Feng Li, Hongying Zhao, Yongjuan Tang, Ke Xue, Xiaomeng Zhang, Weixin Liang, Rui Zhao, Xingyu Lv, Xinyu Song, Chunlong Zhang, Yanjun Xu, Yunpeng Zhang, 2023
Functional regulations between genetic alteration-driven genes and drug target genes acting as prognostic biomarkers in breast cancer, Li Wang, Lei Yu, Jian Shi, Feng Li, Caiyu Zhang, Haotian Xu, Xiangzhe Yin, Lixia Wang, Shihua Lin, Anastasiia Litvinova, Yanyan Ping, Shangwei Ning, Hongying Zhao, 2022

Cancer Omics Bioinformatics Big Data Artificial Intelligence Deep Learning Treatment Prognosis Platform Construction

Hongbo Xie - Harbin Medical University

Qing Jin - Harbin Medical University

Li Xia - Harbin Medical University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us